Opioid Induced Side Effects Treatment Market Trends 2020: Comprehensive Insights on Top Key Players, Technological Scope, Revenue Status, Current Trends and Future Investments

Global Opioid-induced Side Effects Treatment Market – Insights

Opioids are used for pain relief, reversing opioid overdose, suppression of diarrhea and cough, and in replacement therapy for opioid use disorder. Heroin, hydrocodone, oxycodone, morphine, and fentanyl are some examples of opioids. However, continuous use of opioid drugs may lead to opioid addiction and several side effects such as nausea, sedation, constipation, dizziness, vomiting, sweating, headache, and respiratory depression. Other side effects include delirium and drowsiness, which depend on amount of opioid consumed.

To get holistic SAMPLE of the report including table of contents: https://www.coherentmarketinsights.com/insight/request-sample/387

Modifying the dosage of opioids, altering the route of administration, changing the dosing interval, altering the opioid drugs, and replacing the opioids by certain antidepressants and anticonvulsants are some of the recommendations to avoid the side effects induced due to opioids. Risperidone, methylphenidate, cetirizine, and fexofenadine are some of the widely used medications in the treatment of opioid-induced side effects.

Global Opioid-induced Side Effects Treatment Market: Drivers

Increasing number of cocaine-related deaths and high prescription of opioids is expected to boost growth of the global opioid induced side effects treatment market over the forecast period. For instance, according to National Institute on Drug Abuse (NIDA), February 2017, despite decreased use of cocaine after 2010, deaths related to cocaine overdose increased and was associated with opioids, primarily with synthetic opioids. According to the same source, in 2013, the number of prescriptions for opioids was 207 million, globally with North America accounting for major share. Moreover, in 2012, around 2.1 million people in the U.S. suffered from disorders related to prescription opioid pain relievers, of which around 467,000 people were addicted to heroin.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/opioid-induced-side-effects-treatment-market-387

Increasing prevalence of opioids is also expected to aid in growth of the market. For instance, according to United Nations Office on Drugs and Crime (UNODC), 2010, annual prevalence of opioids was around 0.6-0.8% in the people having age group 15-64 and 0.3-0.5% in the people having age more than 64 years. Moreover, increasing number of deaths due to overdose of opioids is also expected to aid in growth of the market.  For instance, according to the CDC, in 2015, over 15,000 deaths were registered in the U.S. due to overdose of opioids and the highest overdose rate was observed in the people between age group of 25-54 years. Moreover, around 2 million people were dependent on prescription opioids in 2014 and prescription opioid receiver for noncancerous pain were 1 in 4 which takes these drugs for addiction. Also, in the U.S., every day, over 1000 people are admitted in emergency department due to misuse of prescription opioids.

Global Opioid-induced Side Effects Treatment Market Taxonomy:

By Dosage Form of Drug

• Solid
• Semi-Solid
• Liquid

By Geography

• North America
• Europe
• APAC
• Latin America
• Middle East
• Africa

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/387

Global Opioid-induced Side Effects Treatment Market: Regional Analysis

On the basis of region, the global opioid-induced side effects treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to account for the largest market share in the global opioid-induced side effects treatment market over the forecast period. This is attributed to high consumption of prescription-based opioids and increasing deaths due to drug overdose in the region. For instance, according to NIDA, in 2013, the U.S. accounted for around 100% consumption of hydrocodone 81% consumption of oxycodone, globally. Moreover, according to American Society of Addiction Medicine (ASAM), drug overdose is the leading cause of death in U.S. and prescription opioids is the leading factor behind it. In 2015, 12,990 deaths were related with prescription-based pain relievers.

The markets in Europe and Asia Pacific are driven by increasing opioid consumption in these regions. For instance, according to UNODC in 2012, Asia Pacific and Africa were the emerging markets for raw opium. Moreover, increasing demand for treatment against drug dependence is also expected to aid in growth of the market in Asia Pacific Europe. The market in Latin America has shown negligible growth in demand for treatment against opioid drug dependency.

Global Opioid-induced Side Effects Treatment Market: Competitive Landscape

Major players operating in the global opioid-induced side effects treatment market include Shionogi & Co., Ltd., Cubist Pharmaceuticals, Inc., AIKO Biotechnology, Inc., SLA Pharma AG, Progenics Pharmaceuticals Inc., and AstraZeneca plc.

Global Opioid-induced Side Effects Treatment Market: Key Developments

Key players in the market are focused on product approval and launch to expand their product portfolio. For instance, in 2014, Naloxone hydrochloride injection (Evzio), a prescription treatment against opioid overdose side effects, received approval from the U.S. Food and Drug Administration (FDA). It is the first auto-injector designed to use outside of the health care setting.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837